Pregled bibliografske jedinice broj: 1260454
Spinal Instability in Rats Counteracted by Pentadecapeptide BPC 157
Spinal Instability in Rats Counteracted by Pentadecapeptide BPC 157 // FASEB Journal
Orlando (FL), Sjedinjene Američke Države: John Wiley & Sons, 2019. str. 8223-8223 doi:10.1096/fasebj.2019.33.1_supplement.822.3 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1260454 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Spinal Instability in Rats Counteracted by
Pentadecapeptide BPC 157
Autori
Dokuzovic, Stjepan ; Bebek, Igor ; Perovic, Darko ; Bilic, Vide ; Corluka, Stipe ; Krezic, Ivan ; Durasin, Tajana ; Drmic, Domagoj ; Seiwerth, Sven ; Sikiric, Predrag
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
FASEB Journal
/ - : John Wiley & Sons, 2019, 8223-8223
Skup
Experimental Biology
Mjesto i datum
Orlando (FL), Sjedinjene Američke Države, 06.04.2019. - 09.04.2019
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
BPC 157 ; spinal instability
Sažetak
To induce spinal instability, we focused on bilateral facetectomy in rats and possible therapeutic benefit with the stable gastric pentadecapeptide BPC 157 given in the drinking water. Recently, using a well-designed rat model (L2-L3 compression), we demonstrated that the stable gastric pentadecapeptide BPC 157 improved the spinal cord injury (FASEB J 2015, 29, 617.5), concluding that under the conditions of one single application, given soon after spinal cord injury, motor function was markedly recovered, axonal and neuronal necrosis was counteracted, as was demyelination and cyst formation. Previously shown to counteract the consequence of peripheral (sciatic) nerve transection/anastomosis, improve nerve healing (Regul Pept. 2010 Feb 25 ; 160(1– 3):33–41.), brain trauma (Regul Pept. 2010 ; 160(1– 3):26–32.), and various encephalopathies (Curr Pharm Des. 2018 ; 24(18):1990–2001), BPC 157 (LD1 not achieved) was implemented as an anti-ulcer peptide in inflammatory bowel disease trials and now in a multiple sclerosis trial(Curr Pharm Des. 2018 ; 24(18):1990–2001). In this study, the bilateral paravertebral muscles attached to the L3–L4 segment were peeled from the lumbar spine to expose the posterior bony elements. The rats then underwent complete resection of bilateral L3–L4 facet joints without neural tissue injuries. The medication was given in drinking water (BPC 157 10 ng/kg, 0.16 ng/mL, 12 ml/rat/day) through next 8 weeks, while controls received drinking water only. Radiological assesment of rat spines acquired at 1 week or 8 weeks was conducted (Figure 1). At 1 week, controls and BPC 157 animals exhibited no gross deformity observed in any plane, disk spaces seem unaffected, neural foramen at operated level is slightly widened, though BPC 157 drinking animals had higher bone density overall. At 8 weeks, both groups exhibited no gross deformity observed in any plane, unaffected disk spaces, widened neural foramen at the operated level is slightly widened, though there was an additional discrepancy in bone density overall between groups (BPC 157 having markedly more sclerotic and better defined bones). Also worth noting is the lack of abundant callus formation in the BPC 157 rats whereas the controls have visible callus formation in seemingly random patterns near the affected level. In addition, a significant motor disability which appears in controls immediately upon injury induction, was completely counteracted in BPC 157 drinking rats.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
MZOS-108-1083570-3635 - Pentadekapeptid BPC 157 - daljnja istraživanja (Sikirić, Predrag, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Predrag Sikirić
(autor)
Sven Seiwerth
(autor)
Ivan Krezić
(autor)
Stipe Ćorluka
(autor)
Vide Bilić
(autor)
Darko Perović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE